management
| home |
| about us |
| products |
| disease mechanism |
| publications |
| media |
| management |
| contact us |
Chief Executive Officer
Dr. G. H. Schmidt PhD email
Director, Chief Medical Officer
Dr. Ivan M. Petyaev MD PhD email
Chief Business Officer
Dr. Nigel K. Davis PhD email
New Products |
||
ATERONON®/TM: A NEW PRESCRIPTION MEDICAL FOOD
Ateronon is a new cardiovascular product (once daily tablet) to be launched in 2008. Read more >
AteroAbzyme®/TMIgG ELISA
A CE marked diagnostic test for lipidoxidation activity. |
||
© Copyright Cambridge Theranostics 2008. Registered in England and Wales No: 4314866; Registered office: 7 Hills Avenue, Cambridge CB1 7UY
class="bodyText">Cambridge Theranostics Ltd .